会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 12. 发明申请
    • Methods for identifying inhibitors of chlorophyll synthase
    • 鉴定叶绿素合酶抑制剂的方法
    • US20050130118A1
    • 2005-06-16
    • US10737014
    • 2003-12-16
    • Abubakr AslamkhanLining GuoRao MulpuriNeil HoffmanSusanne KjemtrupJocelyn KearneyCory ChristensenKeith DavisAdel ZayedRobert AscenziDouglas Boyes
    • Abubakr AslamkhanLining GuoRao MulpuriNeil HoffmanSusanne KjemtrupJocelyn KearneyCory ChristensenKeith DavisAdel ZayedRobert AscenziDouglas Boyes
    • C12Q1/00G01N33/573
    • G01N33/573
    • The present inventors have discovered that antisense suppression of a chlorophyll synthase (CS) gene results in plants exhibiting one or more of chlorosis, reduced growth, and altered development. Thus, the present inventors have discovered that the protein encoded by the CS gene is essential for normal plant growth and development, and is useful as a target for the identification of compounds as antibiotics and herbicides, especially herbicides. The present invention is directed to methods for identifying inhibitors of a CS enzyme by incubating a CS polypeptide with a chlorophyllide and a phopholipid substrate in the presence and absence of a test compound under conditions suitable for the CS enzyme activity, adding a solution to the incubation reactions comprising a water immiscible organic solvent, a water-soluble alcohol, and a water-soluble dye that absorbs in the range of one or both the excitation and emission wavelength ranges of the chlorophyllide substrate, and measuring the fluorescence of the incubation reactions at from about 650 to 750 nm, using from about 425 to 445 nm as excitation wavelength, wherein a decrease in the fluorescence in the presence of the test compound indicates that the compound is a CS inhibitor.
    • 本发明人已经发现,叶绿素合酶(CS)基因的反义抑制导致植物表现出一种或多种褪绿,生长减少和改变发育。 因此,本发明人已经发现,由CS基因编码的蛋白质对于正常的植物生长和发育是必需的,并且可用作鉴定作为抗生素和除草剂,特别是除草剂的化合物的靶标。 本发明涉及通过在适合于CS酶活性的条件下,在存在和不存在测试化合物的情况下,将CS多肽与叶绿素和磷脂底物一起温育来鉴定CS酶抑制剂的方法,向培养基中加入溶液 包括与水不溶混的有机溶剂,水溶性醇和在所述叶绿素底物的激发和发射波长范围中的一个或两个的范围内吸收的水溶性染料的反应,以及测量从 约650至750nm,使用约425至445nm作为激发波长,其中在测试化合物存在下荧光的降低表明该化合物是CS抑制剂。
    • 14. 发明授权
    • Determining liver toxicity of an agent using metabolite biomarkers
    • 使用代谢物生物标志物测定药物的肝脏毒性
    • US08658351B2
    • 2014-02-25
    • US13148082
    • 2010-02-05
    • Michael MilburnLining GuoJacob Edward WulffKay A. Lawton
    • Michael MilburnLining GuoJacob Edward WulffKay A. Lawton
    • C12Q1/00
    • G01N33/5014G01N33/5067G01N33/5088
    • The present invention provides various biomarkers for hepatotoxicity and various methods of using the biomarkers Some of the biomarkers within the scope of this invention are cholate, glycochenodeoxycholate, glycocholate, taurine, 3-hyroxy-2-ethylpropionate, 4-imidazoleacetate, tyramine, anthranilate, 2′-deoxycytidine, N-acetyl aspartate (NAA), beta-hydroxy-hexanoate, and sarcosine (N-methylglycine) The methods of using the biomarkers include exposing a first hepatocyte culture to a test agent and comparing the levels of the one or more biomarkers obtained in the first hepatocyte culture to the levels of the one or more biomarkers obtained in a second hepatocyte culture without the test agent, where differential levels of the one or more biomarkers in the first hepatocyte culture as compared to the levels in the second hepatocyte culture is indicative of the test agent being a hepatotoxicant.
    • 本发明提供用于肝毒性的各种生物标志物和使用生物标志物的各种方法本发明范围内的一些生物标志物是胆酸,甘油脱氧胆酸,甘氨胆酸,牛磺酸,3-羟基-2-乙基丙酸酯,4-咪唑乙酸酯,酪胺,邻氨基苯甲酸酯, 2'-脱氧胞苷,N-乙酰天冬氨酸(NAA),β-羟基己酸酯和肌氨酸(N-甲基甘氨酸)使用生物标志物的方法包括将第一肝细胞培养物暴露于测试试剂,并比较其中一种或多种 在第一肝细胞培养物中获得的更多生物标志物在没有测试剂的第二肝细胞培养物中获得的一种或多种生物标志物的水平,其中第一肝细胞培养物中的一种或多种生物标志物的差异水平与第二次肝细胞培养物中的水平相比 肝细胞培养表明试验剂是肝毒性剂。
    • 15. 发明申请
    • Determination of the Liver Toxicity of an Agent
    • 药物肝脏毒性的测定
    • US20110300571A1
    • 2011-12-08
    • US13148082
    • 2010-02-05
    • Michael MilburnLining GuoJacob Edward WulffKay A. Lawton
    • Michael MilburnLining GuoJacob Edward WulffKay A. Lawton
    • C12Q1/02G01N27/00
    • G01N33/5014G01N33/5067G01N33/5088
    • The present invention provides various biomarkers for hepatotoxicity and various methods of using the biomarkers Some of the biomarkers within the scope of this invention are cholate, glycochenodeoxycholate, glycocholate, taurine, 3-hyroxy-2-ethylpropionate, 4-imidazoleacetate, tyramine, anthranilate, 2′-deoxycytidine, N-acetyl aspartate (NAA), beta-hydroxy-hexanoate, and sarcosine (N-methylglycine) The methods of using the biomarkers include exposing a first hepatocyte culture to a test agent and comparing the levels of the one or more biomarkers obtained in the first hepatocyte culture to the levels of the one or more biomarkers obtained in a second hepatocyte culture without the test agent, where differential levels of the one or more biomarkers in the first hepatocyte culture as compared to the levels in the second hepatocyte culture is indicative of the test agent being a hepatotoxicant.
    • 本发明提供用于肝毒性的各种生物标志物和使用生物标志物的各种方法本发明范围内的一些生物标志物是胆酸,甘油脱氧胆酸,甘氨胆酸,牛磺酸,3-羟基-2-乙基丙酸酯,4-咪唑乙酸酯,酪胺,邻氨基苯甲酸酯, 2'-脱氧胞苷,N-乙酰天冬氨酸(NAA),β-羟基己酸酯和肌氨酸(N-甲基甘氨酸)使用生物标志物的方法包括将第一肝细胞培养物暴露于测试试剂,并比较其中一种或多种 在第一肝细胞培养物中获得的更多生物标志物在没有测试剂的第二肝细胞培养物中获得的一种或多种生物标志物的水平,其中第一肝细胞培养物中的一种或多种生物标志物的差异水平与第二次肝细胞培养物中的水平相比 肝细胞培养表明试验剂是肝毒性剂。
    • 19. 发明申请
    • Methods for identifying inhibitors of sterol 14-alpha-demethylase
    • 确定甾醇14-α-脱甲基酶抑制剂的方法
    • US20050074829A1
    • 2005-04-07
    • US10678571
    • 2003-10-03
    • Abubakr AslamkhanLining GuoJohn Rice
    • Abubakr AslamkhanLining GuoJohn Rice
    • C12Q1/26C12Q1/32C12Q1/48
    • C12Q1/26C12Q1/32G01N2500/00
    • In the methods of the present invention, the change in absorbance of an obtusifoliol 14α-demethylase (OBT-DM) enzyme upon binding of an inhibitor is used to advantage for the identification of inhibitors of OBT-DM activity. Rather than measuring the absorbance of an OBT-DM/inhibitor complex over a spectrum of wavelengths as described previously, the present invention discloses methods for identifying type II inhibitors of OBT-DM by monitoring the absorbance only at 413 nm and 432 nm. The methods of the invention enable the concurrent testing of multiple compounds using a high throughput format such as with 96- or 384-well plates. The OBT-DM polypeptides of the invention include plant, fungal and human OBT-DM polypeptides, and in particular, Arabidopsis thaliana OBT-DM polypeptide
    • 在本发明的方法中,使用抑制剂结合时,obtusifoliol14α-去甲基化酶(OBT-DM)的吸光度变化有利于鉴定OBT-DM活性的抑制剂。 本发明不是如前所述测量波长范围内的OBT-DM /抑制剂复合物的吸光度,而是通过仅在413nm和432nm监测吸光度来公开鉴定OBT-DM的II型抑制剂的方法。 本发明的方法使得能够使用高通量形式(例如96孔或384孔板)同时测试多种化合物。 本发明的OBT-DM多肽包括植物,真菌和人类OBT-DM多肽,特别是拟南芥OBT-DM多肽